Estrogens stimulate proliferation and enhance survival of the prolactin (PRL)-producing lactotroph of the anterior pituitary gland and induce development of PRL-producing pituitary tumors in certain inbred rat strains but not others. The goal of this study was to elucidate the genetic bases of estrogen-induced pituitary tumorigenesis in reciprocal intercrosses between the genetically related AC I and Copenhagen (COP) rat strains. Following 12 weeks of treatment with the synthetic estrogen diethylstilbestrol (DES), pituitary mass, an accurate surrogate marker of absolute lactotroph number, was increased 10.6-fold in AC I rats and 4.5-fold in COP rats. Composite interval mapping analyses of the phenotypically defined F 2 progeny from the reciprocal crosses identified six quantitative trait loci (QTL) that determine the pituitary growth response to DES. These loci reside on chromosome 6 [Estrogen-induced pituitary tumor (Ept)1], chromosome 3 (Ept2 and Ept6 ), chromosome 10 (Ept9 ), and chromosome 1 (Ept10 and Ept13). Together, these six Ept loci and one additional suggestive locus on chromosome 4 account for an estimated 40% of the phenotypic variance exhibited by the combined F 2 population, while 34% of the phenotypic variance was estimated to result from environmental factors. These data indicate that DES-induced pituitary mass behaves as a quantitative trait and provide information that will facilitate identification of genes that determine the tumorigenic response of the pituitary gland to estrogens.
STROGENS play a central role in the regulation of enlarged pituitary glands, commonly referred to as pituitary tumors, exhibit diffuse lactotroph hyperplasia histocell proliferation and survival in numerous mammalian tissues and are implicated in the etiology of several logically and result in marked hyperprolactinemia (Spady et al. 1998b (Spady et al. , 1999b . In contrast, continuous estrogen types of cancer (Shull 2002) . The prolactin (PRL)-producing lactotroph of the anterior pituitary gland protreatment induces very little pituitary growth in other rat strains, such as the outbred Holtzman strain (Wiklund et vides a well-defined cell model for studying estrogen action. It is well established that estrogens enhance tranal. 1981b; Wiklund and Gorski 1982) or the inbred Brown Norway (BN) strain ; Wendell scription of the PRL gene, stimulate lactotroph proliferation, and promote lactotroph survival (Spady et al. and Gorski 1997; Spady et al. 1999d) . The genetic bases of sensitivity of the F344 rat strain 1999b). Continuous treatment with either naturally octo estrogen-induced pituitary growth have been investicurring or synthetic estrogens induces rapid and susgated in crosses to the insensitive Holtzman and BN tained growth of the anterior pituitary gland in male strains. Following 8 weeks of treatment with the synthetic or female rats of the Fischer 344 (F344) (Segaloff and estrogen diethylstilbestrol (DES), average pituitary mass Dunning 1945; Wiklund et al. 1981a,b; was increased 7.8-fold in female F344 rats but was unafGorski 1982), A ϫ C Irish (ACI) (Segaloff and Dunn- fected in female Holtzman rats (Wiklund et al. 1981a (Wiklund et al. ). ing 1945 Holtzman et al. 1979; Shull et al. 1997; Average pituitary mass was increased 1.8-and 2.2-fold in et al. 1999c,d) , Copenhagen (COP) (Spady et al. 1998a , DES-treated (Holtzman ϫ F344)F 1 and (F344 ϫ Holtz1999d), and several other inbred rat strains (Noble et al. man)F 1 rats, respectively, suggesting that sensitivity to 1940; Furth et al. 1973; Spady et al. 1999b) . The grossly DES-induced pituitary growth is recessive or incompletely dominant in these crosses. More recently, Wendell and colleagues (Wendell et al. , 2000 Wen- treatment. The pituitary gland was immediately removed and strains and have mapped six genetic loci, each of which weighed. Pituitary mass in estrogen-treated rats correlates harbors one or more genes that control the pituitary highly with pituitary DNA content (Wiklund et al. 1981b;  growth response to DES in these crosses. The effects of Wendell et al. 2000) and with circulating PRL (Spady et al. two of these loci have now been evaluated using con1999d), indicating that pituitary mass serves as an accurate surrogate indicator of absolute lactotroph number. The spleen genic rat lines Pandey et al. 2004) .
was collected as a source of DNA and stored at Ϫ80Њ.
Together, these studies indicate that estrogen-induced
Analysis of genotypes:
The phenotypically defined (COP ϫ pituitary growth behaves as a quantitative trait in these ACI)F 2 population described herein and the (ACI ϫ COP)F 2 crosses between the F344 and BN rat strains.
population described by us previously (Spady et al. 1999d) We are studying the genetically related ACI and COP were subjected to genotypic analyses. DNA was isolated from the spleen of 162 of 163 (COP ϫ ACI)F 2 rats and 102 of rat strains to define the genetic bases of the differing 103 (ACI ϫ COP)F 2 rats using DNeasy columns (QIAGEN, sensitivities of these strains to estrogen-induced pituitary Valencia, CA). One rat from each cross was excluded from growth (Spady et al. 1999d; Harvell et al. 2003) as well analysis because tissue was not available for isolation of DNA.
as susceptibility to estrogen-induced mammary cancer
The marker panel for QTL mapping consisted of simple se- (Shull et al. 1997; Spady et al. 1998a; quence length polymorphisms (SSLP) that were selected at ‫-02ف‬cM intervals from those distributed across the 20 autosomes 2000; Shull et al. 2001; Gould et al. 2004 1994) . IM was performed hr dark conditions. This facility was accredited by the Ameriusing data for 178 markers distributed across the 20 autosomes. can Association for Accreditation of Laboratory Animal Care
Because similar regions of the genome were indicated to harand operated in accordance with the standards outlined in bor QTL during the initial analyses of the two phenotypically the Guide for the Care and Use of Laboratory Animals (DHHS extreme populations and there was no significant difference in Pub. 85-23). The animals were caged and fed as described the pituitary mass phenotype between the two F 2 populations, previously (Spady et al. 1999d) . Female COP rats were mated these two populations were combined to provide additional to male ACI rats to produce (COP ϫ ACI)F 1 progeny, F 1 power to detect QTL. Permutation-derived thresholds were progeny were mated to generate (COP ϫ ACI)F 2 progeny, again calculated and IM was performed on all autosomes for and ACI females were mated to F 1 males to produce (COP ϫ the combined selective population of 89 F 2 animals. The re-ACI)BC progeny. Pups were weaned at 20-24 days of age.
maining 117 (COP ϫ ACI)F 2 and 58 (ACI ϫ COP)F 2 animals Implants, either empty or containing 5 mg of DES (Sigma, St.
were subsequently genotyped across those chromosomes that Louis), were made from Silastic tubing and medical adhesive exhibited at least suggestive evidence of a QTL upon analysis (Dow Corning, Midland, MI) and were inserted subcutaneof the phenotypically extreme F 2 animals. Permutation-derived ously in the interscapular region as described previously thresholds were then calculated and IM was performed using (Spady et al. 1998a) . Treatment with DES was initiated when the data from the 264 F 2 animals. the animals were 63 Ϯ 4 days of age. Small populations of Composite interval mapping: Composite interval mapping male rats of each genetic type received empty implants. The rats were killed by decapitation after 12 weeks of DES or sham (CIM) was performed using MapManager QTX to reduce the effect of unlinked and linked QTL on each locus mapped (Zeng 1993 (Zeng , 1994 Teuscher et al. 1999; Doerge 2002) . The markers included as cofactors in the CIM analyses were identified using a stepwise selection process and the marker regression function of MapManager QTX. For each step, marker regression was performed across the six chromosomes of interest using the log 10 -transformed pituitary mass as the phenotype, and the marker exhibiting the most statistically significant likelihood-ratio statistic (LRS) was added to the background. This process was repeated until no additional marker exhibited a statistically significant LRS value (Manly et al. 2001) . For each CIM analysis, a marker (for QTL near a chromosome end) or markers (for QTL not near a chromosome end) flanking the test interval as well as the peak marker associated with the five other significant QTL were added to the model as cofactors. The permutation-derived threshold was then calculated by performing 1000 permutations of the phenotypic data and CIM was conducted to determine the effect of the test interval with these cofactors included in the model. This process was performed for each significant QTL. To determine the effect of the significant QTL on the suggestive QTL , CIM was performed with the peak marker associated with the six Figure 1 .-Sensitivity to DES-induced pituitary growth in significant QTL added to the model as cofactors. The confiprogeny from a COP ϫ ACI cross is genetically determined. dence interval for each significant QTL identified by CIM Male ACI, COP, F 1 , F 2 , and BC rats from a cross originating analysis was estimated using bootstrapping analysis (Visscher with COP females and ACI males were generated and treated et al. 1996) , which is part of the interval-mapping function of with DES for 12 weeks beginning at 9 weeks of age as described MapManager QTX. For each significant QTL , the percentage in materials and methods. Each data bar represents the of trait variance explained and the additive effect was determean mass of the anterior pituitary gland in milligrams Ϯ the mined by CIM analysis (Manly et al. 2001) . Degree of domistandard deviation of the mean. Each of the untreated control nance was calculated using CIM analysis and the method of groups consisted of 5-6 rats. The numbers of DES-treated rats Falconer and Mackay (1996) .
were: ACI, 14; COP, 14; F 1 , 18; F 2 , 163; and BC, 49. The Evaluation of genetic interactions: Potential interaction beWilcoxon rank sum test was performed to assess differences tween the 58 markers resident on the six chromosomes that in pituitary mass between experimental groups. P-values Յ0.05 yielded suggestive or significant evidence of a QTL was evaluwere considered indicative of statistical significance. Numeral ated pairwise using MapManager QTX. For this analysis, the 1 indicates a statistically significant difference between a DESthreshold for significance was obtained by performing 1000 treated population and its corresponding sham-treated conpermutations of the phenotypic data using the interaction trol population. Numeral 2 indicates a significant difference model with the level of significance set at P ϭ 0.01 (Manly between the indicated population and the treatment-matched et al. 2001). Interaction testing was performed with the proba-ACI population. Numeral 3 indicates a significant difference bility of a type I error set at Յ10 Ϫ5 (Manly et al. 2001) .
between the indicated population and the treatment-matched Statistical analyses: Differences in pituitary mass between COP population. experimental groups were assessed using the Wilcoxon rank sum test (GB-STAT, version 6.5; Dynamic Microsystems, Silver Spring, MD). P-values Յ0.05 were considered to be indicative itary mass only 4.4-fold in male COP rats, from 7.6 mg of statistical significance. The distribution of pituitary mass (SD ϭ 1.0) to 34.2 mg (SD ϭ 5.9). The pituitary growth and log 10 -transformed pituitary mass values within the comresponse of the DES-treated (COP ϫ ACI)F 1 progeny bined F 2 population was tested for normality using SPSS version 12.0 (SPSS, Chicago). The contribution of environmental was intermediate to that exhibited by the parental ACI factors to phenotypic variance was estimated using the method and COP strains, indicating that this phenotype behaves of Wright (1968).
as an incompletely dominant trait. In these F 1 progeny, DES increased pituitary mass 6.9-fold, from 8.2 mg (SD ϭ 1.2) to 56.6 mg (SD ϭ 13.2). Male (COP ϫ RESULTS ACI)F 2 rats exhibited a 7.8-fold increase in pituitary mass when treated with DES, whereas DES treatment Phenotypic characterization of progeny from a COP ϫ ACI cross: Treatment with the synthetic estrogen DES increased pituitary mass 9.2-fold in male (COP ϫ ACI)BC rats. Pituitary mass in untreated rats did not for 12 weeks resulted in significant increases in pituitary mass in each of the experimental groups evaluated in the differ significantly between groups (Figure 1 ). The pituitary growth responses exhibited by the DEScontext of the COP ϫ ACI (strain of the female is indicated first) cross, relative to that observed in untreated treated male F 1 , F 2 , and BC populations evaluated in this COP ϫ ACI cross were compared to the responses male rats (Figure 1) . However, the magnitude of the pituitary growth response to DES was rat strain specific exhibited by DES-treated F 1 , F 2 , and BC populations evaluated in an ACI ϫ COP cross that was described by and genetically determined. DES increased pituitary mass in male ACI rats 10.6-fold, from 7.7 mg [standard us previously (Spady et al. 1999d) . DES-induced pituitary growth was similar for each of the F 1 , F 2 , and BC deviation (SD) ϭ 0.9] in untreated male ACI rats to 81.7 mg (SD ϭ 10.3). By contrast, DES increased pitupopulations from the two crosses (Table 1) , indicating BC progeny from these reciprocal crosses between the ACI and COP strains. Table 2 summarizes the combined data from the two crosses.
permutation-derived threshold for suggestive evidence of a QTL (data not shown). Mapping of QTL that control estrogen-induced pituitary growth: Genotypes were initially determined at 178 CIM was performed to evaluate these QTL further. The CIM analyses revealed six statistically significant SSLP markers distributed across the 20 autosomes for 45 DES-treated (COP ϫ ACI)F 2 and 44 DES-treated (ACI ϫ QTL residing on RNO1, RNO3, RNO6, and RNO10 ( Figure 2 ). These loci have been designated as Estrogen-COP)F 2 progeny that exhibited the extreme phenotypes, i.e., the largest or smallest pituitary masses, within their induced pituitary tumor (Ept) loci: Ept1, Ept2, Ept6, Ept9, Ept10, and Ept13. The numbering of these QTL is not respective populations. Interval-mapping analyses of each of these F 2 subpopulations provided suggestive evicontinuous because other Ept loci not described here have been mapped in other crosses between the ACI dence for the presence of QTL affecting pituitary mass on RNO3, RNO6, and RNO10 (data not shown). Beand Brown Norway strains (T. E. Strecker and J. D. Shull, unpublished data). Ept1 is defined by a peak cause the (COP ϫ ACI)F 2 and (ACI ϫ COP)F 2 populations did not differ from one another phenotypically LRS value of 20.4 at D6Rat80 and a confidence interval extending from D6Rat150 to D6Rat39 (Figure 2A ). This (Table 1 ) and the preliminary interval-mapping analyses of the two subpopulations of phenotypically extreme F 2 locus is estimated to account for 8% of the phenotypic variance exhibited by the combined F 2 population (Taprogeny were suggestive of similar QTL, the two subpopulations were combined to increase statistical power. ble 3). Ept2 is defined by a peak LRS value of 38.4 near D3Rat26, with the confidence interval defined by Interval-mapping analysis of this combined population of 89 phenotypically extreme F 2 progeny revealed a total D3Rat130 and D3Rat21 ( Figure 2B ). Ept2 is estimated to account for 14% of the phenotypic variance and of eight regions on RNO1, RNO3, RNO4, RNO5, RNO6, and RNO10 where LRS values exceeded 10.6, the perexerts the strongest effect on DES-induced pituitary mass of the six QTL (Table 3) . Ept6 also maps to RNO3 mutation-derived threshold indicative of suggestive evidence for the presence of a QTL affecting pituitary mass ( Figure 2C ). This QTL is defined by a peak LRS value of 30.6 at D3Mgh9, a confidence interval extending from (data not shown). Genotypes were subsequently determined at 58 SSLP markers spanning these six chromoD3Mgh16 to D3Rat277, and accounts for ‫%11ف‬ of the phenotypic variance (Table 3) . Ept9 is defined by a peak somes for the remaining 117 DES-treated (COP ϫ ACI)F 2 progeny and the remaining 58 DES-treated (ACI ϫ LRS value of 17.9 near D10Mit7 and a confidence interval extending from D10Rat27 to D10Rat11 ( Figure 2D ). COP)F 2 progeny. Interval-mapping analyses of this combined population of 264 DES-treated F 2 progeny reThis QTL is estimated to account for 7% of the phenotypic variance (Table 3) . Both Ept10 and Ept13 map to vealed one locus on RNO3 where the peak LRS value exceeded 20.9, the permutation-derived threshold in-RNO1. Ept10 is defined by an LRS peak of 17.4 near D1Rat119 and a confidence interval extending from dicative of highly significant evidence of a QTL; a total of four loci on RNO1, RNO3, RNO6, and RNO10 where D1Rat133 to D1Rat81 ( Figure 2E ). Ept13 is defined by a peak LRS value of 15.6 near D1Rat192 and a confidence the peak LRS values exceeded 14.0, the permutationderived threshold indicative of significant evidence of interval extending from D1Rat192 to D1Rat259 ( Figure  2F ). Ept10 and Ept13 are estimated to account for 7 and a QTL; and three additional loci on RNO1, RNO4, and RNO5 where the peak LRS values exceeded 7.9, the 6% of the phenotypic variance, respectively (Table 3) . Genetics of Pituitary Tumorigenesis Figure 2. -Six quantitative trait loci determine sensitivity to DES-induced pituitary growth in F 2 progeny from reciprocal crosses between the ACI and COP rat stains. Genotypes were determined at the indicated polymorphic SSLP markers for a total of 264 phenotypically defined F 2 progeny from reciprocal crosses between the ACI and COP strains. Each horizontal axis represents the genetic map of the indicated rat chromosome in Haldane centimorgans and the markers at which genotypes were determined. Each vertical axis represents the LRS value for the correlation between log 10 -transformed pituitary mass and genotype along each chromosomal interval as determined by CIM. Each solid box represents the bootstrapping-derived confidence interval. (A) Ept1 is defined by an LRS peak of 20.4 at D6Rat80 and a confidence interval of ‫51ف‬ cM extending from D6Rat150 to D6Rat39. Permutationderived thresholds for significant (14.3; solid line) and highly significant (19.6; dotted line) evidence of a QTL are shown. (B) Ept2 is defined by an LRS peak of 38.4 between D3Rat37 and D3Rat26 and a confidence interval of ‫84ف‬ cM from D3Rat130 to D3Rat21. Permutation-derived thresholds for significant (13.7; solid line) and highly significant (20.0; dotted line) evidence of a QTL are shown. (C) Ept6 is defined by an LRS peak of 30.6 at D3Mgh9 and a confidence interval of ‫71ف‬ cM from D3Mgh16 to D3Rat277. Permutation-derived thresholds for significant (14.0; solid line) and highly significant (20.5; dotted line) evidence of a QTL are shown. (D) Ept9 is defined by an LRS peak of 17.9 between D10Rat21 and D10Mit7 and a confidence interval of ‫53ف‬ cM from D10Rat27 to D10Rat11. The permutation-derived threshold (14.1) for significant evidence of a QTL is shown. (E) Ept10 is defined by an LRS peak of 17.4 between D1Rat119 and D1Rat81 and a confidence interval of ‫06ف‬ cM from D1Rat133 to D1Rat81. The permutation-derived threshold (14.2) for significant evidence of a QTL is shown. (F) Ept13 is defined by an LRS peak of 15.6 at D1Rat192 and a confidence interval of ‫75ف‬ cM from D1Rat192 to D1Rat259. The permutation-derived threshold for significant (14.5) evidence of a QTL is shown.
When CIM analysis was performed for the suggestive estimated to account for 40% of the phenotypic variance, whereas environmental factors are estimated to QTL on RNO4, a peak LRS value of 11.1 was observed at D4Mgh7. Although this LRS value exceeded the peraccount for 34% of the variance. Impact of Ept loci on pituitary mass: Data presented mutation-derived threshold suggestive of a QTL (7.6), it did not exceed the threshold indicative of a significant above indicate that growth response of the pituitary gland to DES is determined by a minimum of six QTL. QTL (14.0). By contrast, CIM-derived LRS values on RNO5 did not exceed the permutation-derived thresh-CIM analyses indicate that ACI alleles of Ept1, Ept2, Ept9, and Ept13 confer increased pituitary mass in response to old suggestive of a QTL (7.6). The six significant Ept loci and the suggestive QTL on RNO4 together are DES, whereas COP alleles for Ept6 and Ept10 confer f Degree of dominance (Falconer and Mackay 1996) . 0 indicates additive affects of the ACI and COP alleles; 1 indicates full dominance of the ACI allele; Ϫ1 indicates full dominance of the COP allele.
g Mean pituitary mass (milligrams) in the F 2 subpopulation that is homozygous for the ACI allele at the indicated marker minus mean pituitary mass in the F 2 subpopulation that is homozygous for the COP allele at that marker.
increased mass (Table 3) . Whereas the ACI alleles for marker D1Rat75 had no significant effect on pituitary mass. By contrast, among the F 2 rats that were heterozyEpt2 and Ept9 appeared to act additively, the ACI alleles for the remaining four Ept loci deviated from an additive gous at the Ept9 marker D10Mit7, rats homozygous for the COP allele at the Ept10 marker D1Rat75 exhibited mode of action (Table 3) . When the combined F 2 population was classified into subpopulations according to significantly increased pituitary mass, relative to that exhibited by F 2 rats that were either homozygous for genotype at the marker closest to the LRS peak for each Ept locus, homozygosity for the ACI allele at Ept1, Ept2, the ACI allele or heterozygous at D1Rat75 ( Figure 3B ). The biological significance of this interaction is not Ept9, and Ept13 was associated with 16.3, 24.2, 13.8, and 14.6 mg, respectively, of additional pituitary mass relaknown at this time. tive to rats homozygous for the COP allele at these loci (Table 3) . By contrast, homozygosity for the COP allele DISCUSSION at Ept6 and Ept10 was associated with 19.7 and 15.8 mg, respectively, of additional pituitary mass relative to rats It has been known for Ͼ60 years that chronic treatment with estrogens, either naturally occurring or synhomozygous for the ACI allele. For each of the six Ept loci, the average pituitary mass in F 2 rats homozygous thetic, leads to development of pituitary tumors in rats (Mceuen et al. 1936; Segaloff and Dunning 1945 ; for the ACI allele differed significantly from that observed in the F 2 rats that were homozygous for the COP Clifton and Meyer 1956) and mice (Gardner and Strong 1940; Gardner 1941; Spady et al. 1999b ). Moreallele.
Epistatic interaction between Ept9 and Ept10: Map over, substantial evidence suggests that estrogens may contribute to development of pituitary tumors in huManager QTX was used to evaluate potential pairwise interactions between the 58 markers residing on the six mans (Landolt et al. 1984; Holmgren et al. 1986; Miyai et al. 1986; Gooren et al. 1988; Panteon et al. 1988 ; chromosomes demonstrated to harbor the six Ept loci or to have yielded suggestive evidence of a QTL during Bevan et al. 1989; Kovacs et al. 1994) . However, the mechanisms through which estrogens induce pituitary interval mapping. A single, statistically significant interaction was detected between D10Mit7, which resides tumor development remain poorly defined. Elucidation of the genetic bases of the differing sensitivities of the within Ept9, and D1Rat75, which resides within Ept10. This interaction yielded an LRS value of 44.1, which genetically related ACI and COP rat strains to DESinduced pituitary growth will likely provide novel inexceeded the permutation-derived threshold, 42.0, indicative of highly significant evidence of interaction. To sights into the mechanisms through which estrogens regulate pituitary lactotroph homeostasis and induce illustrate the nature of this interaction, the F 2 population was initially subdivided on the basis of genotype at pituitary tumor development. The data presented in this study indicate that estroD10Mit7 and then further subdivided by genotype at D1Rat75 (Figure 3 ). In F 2 rats homozygous for either gen-induced pituitary growth behaves as a quantitative trait in reciprocal crosses between the ACI and COP the ACI allele ( Figure 3A) or the COP allele ( Figure  3C ) at the Ept9 marker D10Mit7, genotype at the Ept10 rat strains. Six QTL that determine sensitivity to DES- Figure 3. -Characterization of the interaction between Ept9 and Ept10. Each of the 264 phenotypically defined F 2 rats from the reciprocal crosses between the ACI and COP rat strains was classified by genotype at the Ept9 marker D10Mit7 and then further classified by genotype at the Ept10 marker D1Rat75. Each data bar represents the mean mass of the anterior pituitary gland in milligrams Ϯ the standard error of the mean. The Wilcoxon rank sum test was performed to assess differences in pituitary mass between the genotypically defined subpopulations. P-values Յ0.05 were considered indicative of statistical significance. Numeral 1 indicates that pituitary mass differs significantly from that observed in the subpopulation homozygous for the ACI allele at D1Rat75. Numeral 2 indicates that pituitary mass differs significantly from that observed in the subpopulation homozygous for the COP allele at D1Rat75.
induced pituitary growth have been mapped through related ACI strain. Rather, the sensitivity of the COP strain to DES-induced pituitary growth is due, at least CIM analyses of the F 2 populations generated in these crosses. Thus, the genetic bases of estrogen-induced in part, to the action of growth-conferring alleles not carried by the ACI strain. Interestingly, we have prepituitary tumor development in these crosses are more complex than proposed by us previously (Spady et al. viously demonstrated that a 40% restriction of dietary energy consumption inhibits estrogen-induced pituitary 1999d). We have estimated that these six Ept loci, together with one suggestive locus, account for 40% of growth in COP, but not ACI, rats (Spady et al. 1999a,c; Harvell et al. 2001 Harvell et al. , 2002 Harvell et al. , 2003 . Together these data the phenotypic variance exhibited by the combined F 2 population from the two crosses. Environmental factors suggest that the mechanism underlying estrogeninduced pituitary growth in the ACI rat strain differs, were estimated to account for an additional 34% of phenotypic variance. These data suggest that one or more unat least in part, from that in the COP strain. Wendell et al. have mapped to RNO2, RNO3, RNO5, mapped Ept loci account for the estimated 26% of the phenotypic variance that remains unexplained. It is posand RNO9 a total of six QTL, referred to as Estrogendependent pituitary mass (Edpm) loci, that affect DESsible that an unmapped Ept locus may reside within a region of the rat genome too distant from the nearest induced pituitary growth in female F 2 and BC progeny derived from crosses between the F344 and BN rat polymorphic marker to allow the locus to be detected. Seven segments of the rat genome exist where an addistrains (Wendell and Gorski 1997; Wendell et al. 2000) . Data from our study of male F 2 progeny from tional Ept locus, were it to reside there, would be 20-28 cM from the nearest polymorphic marker. These segcrosses between the ACI and COP rat strains specifically exclude pituitary growth-controlling loci from the rements are located on RNO1, -2, -5, -6, -7, -10, and -17. Moreover, the X and Y chromosomes were not fully gions of RNO2, RNO5, and RNO9 to which Wendell et al. mapped five of the six loci that control DES-induced evaluated in this study. Therefore, we cannot exclude these chromosomes as determinants of the pituitary pituitary growth in the F344 ϫ BN crosses. The Ept2 locus mapped by us to RNO3 overlaps with the Edpm3 growth response to DES. Alternatively, the remaining 26% of the phenotypic variance could result from the locus mapped by Wendell et al. Thus, five of the six Ept loci mapped in the ACI ϫ COP crosses are clearly disactions of multiple unmapped Ept loci, each of which would exert an effect on pituitary mass that was too tinct from those mapped by Wendell et al. in crosses between the F344 and BN strains. We hypothesize that small to be detected in our analyses (Van Ooijen 1992; Muranty and Goffinet 1997) .
the dissimilarities in the QTL mapped in our study compared to those of Wendell et al. result from differThe six Ept loci mapped in this study segregate and appear, for the most part, to function independently of ences in the inbred strains being evaluated. However, we cannot exclude the possibility that the differences one another. ACI alleles at Ept1, Ept2, Ept9, and Ept13 are associated with increased DES-induced pituitary growth, in the QTL identified in the two studies are due to variation in experimental design, such as the gender of relative to COP alleles at these loci. In contrast, COP alleles at Ept6 and Ept10 are associated with increased pituitary rats used for linkage analysis. We observed highly significant evidence of an epigrowth. Thus, the sensitivity of the COP strain to DESinduced pituitary growth is not simply due to the action static interaction between Ept9 and Ept10. The potential interaction between Ept9 and Ept10 is particularly intriof growth-conferring alleles shared with the genetically this manuscript. This work was supported by National Institutes of guing because Jak2 resides within the Ept10 interval, 
